This thread isnt really a thread at all; although you are welcome to suggest additional rules of engagement. Its aim is to outline what is generally expected of everyone who follows/participates in the main Bio threads, and to inform you where other related specialist threads are lurking. The aim is to avoid the chaos of […]
Articles
- Most Relevant
- Most Recent
Jackpot Digital OTC JPOTF TSXV JP Interesting but very speculative but near bottom of price range. I do like the business model. Please do your own due diligence. The Company’s primary business model is the licensing of its ETG tables to casino operators in exchange for a monthly recurring revenue stream. LOL from website—watch it […]
This ad comes to us from Andrew Mickey at Breakaway Investor, who we’ve heard from a few times before. The solution was suggested by a few readers, the first of whom was Randy Last-name-withheld-to protect-the-innocent, and one of them, one of the Stock Gumshoe Irregulars who wishes to remain anonymous (we’ll call him Streetsifter … […]
[Ed. Note: Dr. KSS writes about medicine biotech stocks for the Gumshoe Irregulars. He chooses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe page for his past articles and most recent comments.] Assessing biotechnology stocks involves use of lots of mental microscopes and magnifying lenses. But the task […]
Since I added to a telecom/5G stock today, and I see that same stock being teased again this week, I thought I’d take this Friday opportunity to solve a teaser for you as I update you on my portfolio moves. The teaser is from Michael Robinson for his Nova-X Report ($79/year), and it sounds kind […]
“Buying PURE gold bullion for $421 an ounce while retail investors are paying $1,700 for the EXACT same gold?” That’s the promise from a recent ad for GoldProfitFormula.com, and, though it turns out it’s not a pitch for a stock this time around, I thought I’d spend a few minutes on the ad — in […]
It’s the end of the year, so we’re running into all those stories again about how this is the longest expansion in history, and we have never gone this long without seeing a 20% (or more) drop in the market. Which, of course, fires up the market timer in all of us — especially now […]
This is the third time I’ve bought an IPO on its first day of trading, and the second time I’ve bought exposure to a SPAC over the past year — hopefully it will work out as well as the others. I saw Chamath Palihapitiya speak at the Delivering Alpha conference on Tuesday, along with Starwood’s […]
Some more stocks from our list of speculative ideas to run through today, let’s jump right in with a look at Ligand Pharmaceuticals (LGND) and Invensense (INVN), two of the faster-growing stocks I’ve covered that are seeing rapid change, and do a quick check-in on some other tech-related stocks in our speculation list that haven’t […]
Investors always worry about the so-called “value trap,” a company that looks cheap but will forever remain cheap, luring investors in with a low PE ratio and miring them in the muck for years as they wait for others to see the “value” — sometimes we’ll also see “dividend traps,” where stocks entice investors with […]
A couple notes for you before I get into the investment idea that I want to feature this month: First, thanks to the new folks who have joined this week — quite a few folks came on board in response to the teaser barrage for Sandstorm Gold, which is still being very actively teased by […]
This is the first ticker specific discussion…..if it works, there may be many others. The aim is to have a chronological knowledge diary. If your comment is about ANYTHING other than $ARTH…please DONT post it here. **Please note that this post has been closed to further comment. The discussion on ARTH has moved over to […]
This thread was initiated in order to provide a dedicated page for the members interested in following developing events at Aptose Biosciences. All posts made here should be about it. Other comments about biotech should be posted to the latest general purpose biotech thread, which on the date this is being written is https://www.stockgumshoe.com/2018/02/biotech-discussion-continued/ , […]
[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]
So currently we are working on the short term 5G, sell-driving vehicles, AI/DL/ML, and electric vehicles.I have strong interest in Blockchain, financial privacy (I am tired of being taxed 5 times for every dollar and for even investments in Crypto). But also it provides a OpenBanking, OpenTrading. Crypto is not just ’coins’ the Blockchain is […]
So currently we are working on the short term 5G, sell-driving vehicles, AI/DL/ML, and electric vehicles.I have strong interest in Blockchain, financial privacy (I am tired of being taxed 5 times for every dollar and for even investments in Crypto). But also it provides a OpenBanking, OpenTrading. Crypto is not just ’coins’ the Blockchain is […]
So currently we are working on the short term 5G, sell-driving vehicles, AI/DL/ML, and electric vehicles.I have strong interest in Blockchain, financial privacy (I am tired of being taxed 5 times for every dollar and for even investments in Crypto). But also it provides a OpenBanking, OpenTrading. Crypto is not just ’coins’ the Blockchain is […]
Lots of folks have been asking me about Bitcoin and Ethereum and the other alt-currencies of late, for obvious reasons (well, it’s obvious why folks are curious about it — far less obvious why anyone would seek my wisdom on the subject)… so I’ve got an extended bit of blather about those currencies to share […]
[ed. note: Michael Jorrin, who I like to call “Doc Gumshoe,” is a medical writer (not a doctor) who shares his thoughts with our readers a couple times a month. He does not generally cover investing topics, but I find his discussions of broader health issues interesting and useful. Enjoy!] Doc Gumshoe would not be […]
We’ve got a strange confluence of events here, and it seems like the market is starting to draw dotted lines toward a more optimistic future… no buy or sell changes from me at the moment, just some musings about recent inflation optimism and China optimism, and how that tied in with some excitement over Berkshire’s […]
I’ve spent the past couple weeks going over my updated opinions on all of the past “Idea of the Month” stocks (or at least, those that haven’t already been dropped from coverage over the years), and I promised to put them all in one big list in order of likingness (yes, I know it’s not […]
Over the years I’ve shared a few “Idea of the Month” picks that are plays on various emerging markets — the most direct emerging and frontier market picks have been Lonrho in Africa, Brazil Fast Food in Brazil, and Nagacorp in Cambodia, so let’s check in with those. As with the rest of our annual […]
Over the years I’ve shared a few “Idea of the Month” picks that are plays on various emerging markets — the most direct emerging and frontier market picks have been Lonrho in Africa, Brazil Fast Food in Brazil, and Nagacorp in Cambodia, so let’s check in with those. As with the rest of our annual […]
Over the years I’ve shared a few “Idea of the Month” picks that are plays on various emerging markets — the most direct emerging and frontier market picks have been Lonrho in Africa, Brazil Fast Food in Brazil, and Nagacorp in Cambodia, so let’s check in with those. As with the rest of our annual […]
Over the years I’ve shared a few “Idea of the Month” picks that are plays on various emerging markets — the most direct emerging and frontier market picks have been Lonrho in Africa, Brazil Fast Food in Brazil, and Nagacorp in Cambodia, so let’s check in with those. As with the rest of our annual […]
There’s been a big push on in recent days for subscriptions to some of Doug Casey’s newsletters, with the ad that I’ve been most recently asked about being for a “combo deal” that gets you subscriptions to Casey International Speculator and their flagship Casey Report (for a “discount” price, naturally, though it renews at a […]
Curing the blind — that sounds lovely, eh? That’s the headline of the latest ad from Patrick Cox … … we’ve seen many overpromising ads from Cox’s Breakthrough Technology Alert over the years, and they never fail to catch the attention of the great Gumshoe readership. It is, after all, just the kind of thing […]
I haven’t written much about the Palm Beach Letter, but Tom Dyson and Michael Masterson/Mark Ford have been given free reign to pitch their newsletter to most of the Agora and Stansberry mailing lists, it appears, so we sure see a lot of their ads. And lots of folks have been asking about this one, […]
Fukushima Daini proved that nuclear power is very safe. That wasn’t a typo–Daini, not Daichi. Fukushima Number One (Daichi) is the infamous reactor complex. Fukushima Number Two (Daini) is seven miles down the coast and was also hit by the earthquake and tsunami. (Please see this striking images of the tsunami at Daini: http://depletedcranium.com/dainipics.jpg ) […]
Fukushima Daini proved that nuclear power is very safe. That wasn’t a typo–Daini, not Daichi. Fukushima Number One (Daichi) is the infamous reactor complex. Fukushima Number Two (Daini) is seven miles down the coast and was also hit by the earthquake and tsunami. (Please see this striking images of the tsunami at Daini: http://depletedcranium.com/dainipics.jpg ) […]
Gulf Keystone Petroleum in London is the most successful wildcatter in years,see for yourself.With multi billion barrel discoveries on 4 different licenses they have become a takeover target for IOCs. http://www.gulfkeystone.com/ Check out the progress on Proactive investors http://www.proactiveinvestors.co.uk/LON:GKP/Gulf-Keystone-Petroleum-Ltd. GKP.L in London;GUKYF in USA.
Gulf Keystone Petroleum in London is the most successful wildcatter in years,see for yourself.With multi billion barrel discoveries on 4 different licenses they have become a takeover target for IOCs. http://www.gulfkeystone.com/ Check out the progress on Proactive investors http://www.proactiveinvestors.co.uk/LON:GKP/Gulf-Keystone-Petroleum-Ltd. GKP.L in London;GUKYF in USA.
That provocative headline is there to get your attention, of course — plenty of folks disagree with Warren Buffett on one thing or another, but few believe him to be “mad.” No, what Hilary Kramer is trying to do is to draw your attention to the fact that Buffett finally bought a tech stock, IBM […]
Roger Conrad has been a well known fan of relatively stodgy income stocks for a long time, with his Canadian Edge and Utility Forecaster both ranking among the top income-focused newsletters according to Stock Gumshoe reviewers for most of the past several years. And today’s he’s teasing us with yet another somewhat unusual income investment, […]
As I type this I’m waiting for the deliveryman to arrive, bringing my new router and computer — one thing I can say about life as the Stock Gumshoe, it’s hell on my laptop. The poor thing is so clogged with spam and has been sent on so many forced marches across the internet as […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]